Organon & Co (OGN)
Financial leverage ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 12,058,000 | 11,012,000 | 10,979,000 | 10,763,000 | 10,955,000 | 10,437,000 | 10,614,000 | 10,597,000 | 10,681,000 |
| Total stockholders’ equity | US$ in thousands | -70,000 | -589,000 | -555,000 | -737,000 | -892,000 | -1,066,000 | -1,137,000 | -1,250,000 | -1,508,000 |
| Financial leverage ratio | — | — | — | — | — | — | — | — | — |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $12,058,000K ÷ $-70,000K
= —
As the financial leverage ratio data for Organon & Co. is not provided in the table across the various quarters, a detailed analysis cannot be conducted at this time. The financial leverage ratio, also known as the debt-to-equity ratio, is a key metric that indicates the proportion of a company's assets that are financed through debt compared to equity. It is calculated by dividing total debt by total equity.
To perform a thorough analysis of Organon & Co.'s financial leverage ratio, it would be necessary to have the specific values of total debt and total equity for each quarter listed in the table. By tracking this ratio over time, analysts can assess the company's capital structure, risk exposure, and financial health.
In practice, a decreasing financial leverage ratio may signal a lower level of financial risk and a stronger equity position, while a rising ratio could indicate increasing reliance on debt for funding operations. Future access to the complete financial data would enable a more in-depth evaluation of Organon & Co.'s leverage position and help stakeholders make informed decisions regarding the company's financial strategy.
Peer comparison
Dec 31, 2023